Perpetrator-confessed abusive head trauma cases linked to retinal haemorrhages

Article

The incidence of retinal haemorrhages in abusive head trauma in paediatric patients for known perpetrators, regardless of a confession, is similar, reveals a paper.

The incidence of retinal haemorrhages in abusive head trauma in paediatric patients for known perpetrators, regardless of a confession, is similar, reveals a paper.

A retrospective chart review led by Dr Majida Gaffar, Department of North Shore-Long Island Jewish Health Systems, Great Neck, New York, evaluated the relationship between the presence of retinal haemorrhages and identified perpetrators in 48 cases of abusive head trauma.

All abusive head trauma cases were categorized into perpetrator confessed (Category A), perpetrator identified without confession (Category B) and no perpetrator identified (Category C).

There were 18 cases in category A, 16 in B and 14 in C with retinal haemorrhages in 88%, 75% and 43% of patients in A, B and C, respectively. There was a statistically significant difference in presence of retinal haemorrhages between categories with the perpetrator identified and no perpetrator identified.

Difference in retinal haemorrhages was linked to higher incidence of acute presentation in the perpetrators identified groups compared to category C. Decreased occurrence of retinal haemorrhages was statistically correlated to a lower incidence of acute presentation in abusive head trauma cases without an identified perpetrator.

The abstract can be read in the Journal of Paediatric Ophthalmology and Strabismus.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.